Clinical trials
Scleroderma, Diffuse trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Children's Hospital of Fudan University | 1 |
| Novartis Pharmaceuticals | 1 |
| Peking Union Medical College Hospital | 1 |
| Prolium Bioscience, Inc | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shenzhen MagicRNA Biotechnology Co., Ltd | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 12 |
| Autoimmune Diseases | 4 |
| Lung Diseases, Interstitial | 4 |
| Lupus Erythematosus, Systemic | 4 |
| Scleroderma, Systemic | 3 |
| Arthritis, Rheumatoid | 2 |
| Connective Tissue Diseases | 2 |
| Sjogren's Syndrome | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Antiphospholipid Syndrome | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.